Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab
Crossref DOI link: https://doi.org/10.1007/s40259-016-0184-3
Published Online: 2016-07-26
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Jennifer
Eris, Tamer
Li, Cynthia
Cao, Shawn
Kuhns, Scott
Funding for this research was provided by:
Amgen, Inc.
License valid from 2016-07-26